Monoclonal antibodies -- treatments developed by cloning a cell that makes an antibody -- could help provide an answer to the growing problem of antimicrobial resistance, say scientists.
Antimicrobial resistance is one of the major global health threats. And the traditional approach is to look for new antibiotics and to completely fail, generating monstrous bacteria resistant to all drugs.To launch the alarm is Rino Rappuoli, Scientific Director of the Biotecnopolo Foundation of Siena, in an article published in the magazine Trends in Immunology together with some colleagues. The solution, according to the authors, could come fr…